Nintedanib in chronic fibrosing interstitial lung diseases. A case series

Progressive pulmonary fibrosis (PPF) can be fatal in non-idiopathic interstitial lung diseases. We report a descriptive series of 13 patients with PPF who received treatment with nintedanib, a multitargeted tyrosine kinase inhibitor with antifibrotic effect. Although the reduced number of patients a...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Raquel García Sevila, Juan José Arenas Jiménez, Paloma Vela Casasempere, Ester Nofuentes Pérez, Ignacio Gayá García-Manso
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2024-04-01
Edice:	Heliyon
Témata:	Non-idiopathic interstitial lung diseases Progressive pulmonary fibrosis Antifibrotic therapy Nintedanib
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2405844024044347
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!